{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:29:34Z","timestamp":1786116574464,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02166-6","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:35:02Z","timestamp":1780313702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center"],"prefix":"10.1186","volume":"26","author":[{"given":"Caio Vin\u00edcius","family":"Suartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda Dias","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Henrique Souza","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Narumi Demitrol","family":"Setoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Mazzoneto Te\u00f3filo","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Vasconcelos Henry","family":"Sant\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Guilherme Pereira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonam Bringhenti","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Vion Sant","family":"Galvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio Cordeiro","family":"Dener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Carlos","family":"Nahas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo Alves","family":"Ribeiro-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"3","key":"2166_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2166_CR2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","volume":"74","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder cancer: a systematic review and contemporary update. Eur Urol. 2018;74(6):784\u201395.","journal-title":"Eur Urol"},{"key":"2166_CR3","volume-title":"EAU Guidelines. Presented at the EAU Annual Congress Madrid 2025","author":"European Association of Urology","year":"2025","unstructured":"European Association of Urology. EAU Guidelines. Presented at the EAU Annual Congress Madrid 2025. Arnhem: EAU; 2025."},{"issue":"19","key":"2166_CR4","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"issue":"6","key":"2166_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","volume":"21","author":"M Yin","year":"2016","unstructured":"Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist. 2016;21(6):708\u201315.","journal-title":"Oncologist"},{"issue":"10","key":"2166_CR6","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.ejso.2021.05.007","volume":"47","author":"A Minervini","year":"2021","unstructured":"Minervini A, Di Maida F, Tasso G, Mari A, Bossa R, Sforza S, et al. Robot-assisted radical cystectomy with Florence robotic intracorporeal neobladder (FloRIN): analysis of survival and functional outcomes after first 100 consecutive patients upon accomplishment of phase 3 IDEAL framework. Eur J Surg Oncol. 2021;47(10):2651\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"2166_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/bju.16671","volume":"135","author":"BJ Chow","year":"2025","unstructured":"Chow BJ, et al. Global comparison of research ethical review protocols: insights from an international research collaborative. BJU Int. 2025;135(5):717\u20139.","journal-title":"BJU Int"},{"issue":"5","key":"2166_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/MOU.0000000000000078","volume":"24","author":"M Mossanen","year":"2014","unstructured":"Mossanen M, Gore JL. The burden of bladder cancer care: direct and indirect costs. Curr Opin Urol. 2014;24(5):487\u201391.","journal-title":"Curr Opin Urol"},{"key":"2166_CR9","doi-asserted-by":"publisher","first-page":"eAO5628","DOI":"10.31744\/einstein_journal\/2020AO5628","volume":"18","author":"F Korkes","year":"2020","unstructured":"Korkes F, et al. Mortalidade ap\u00f3s cistectomia radical est\u00e1 fortemente associada ao volume de cirurgias da institui\u00e7\u00e3o. Einstein (Sao Paulo). 2020;18:eAO5628.","journal-title":"Einstein (Sao Paulo)"},{"issue":"1","key":"2166_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00345-023-04742-z","volume":"42","author":"N Pyrgidis","year":"2024","unstructured":"Pyrgidis N, et al. Effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy. World J Urol. 2024;42(1):19.","journal-title":"World J Urol"},{"issue":"6","key":"2166_CR11","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/ans.15259","volume":"89","author":"GD Coughlin","year":"2019","unstructured":"Coughlin GD, Youl PH, Philpot S, Wright MJ, Honore M, Theile DE. Outcomes following radical cystectomy: a population-based study from Queensland, Australia. ANZ J Surg. 2019;89(6):752\u20137.","journal-title":"ANZ J Surg"},{"issue":"5","key":"2166_CR12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/cncr.24052","volume":"115","author":"JL Gore","year":"2009","unstructured":"Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS. Urologic Diseases in America Project. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a SEER-Medicare analysis. Cancer. 2009;115(5):988\u201396.","journal-title":"Cancer"},{"key":"2166_CR13","doi-asserted-by":"crossref","unstructured":"Aldhaam NA, Elsayed AS, Hussein AA, Siam A, Osei J, Jing Z et al. Impact of perioperative multidisciplinary rehabilitation pathway on early outcomes after robot-assisted radical cystectomy: a matched analysis. Urology. 2020;89(6).","DOI":"10.1016\/j.urology.2020.05.113"},{"issue":"6","key":"2166_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.clnu.2013.09.014","volume":"32","author":"Y Cerantola","year":"2013","unstructured":"Cerantola Y, et al. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS) Society recommendations. Clin Nutr. 2013;32(6):879\u201387.","journal-title":"Clin Nutr"},{"issue":"4","key":"2166_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.euo.2018.09.004","volume":"2","author":"L Boeri","year":"2019","unstructured":"Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson MK, et al. Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer is associated with adverse survival outcomes. Eur Urol Oncol. 2019;2(4):390\u20136.","journal-title":"Eur Urol Oncol"},{"key":"2166_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euros.2025.07.010","volume":"79","author":"CV Suartz","year":"2025","unstructured":"Suartz CV, de Lima RD, de Almeida LS, Liebl B, Lopes RI, Branquinho Reis GB, et al. Neoadjuvant immunotherapy in bladder cancer: ushering in a new era of treatment\u2014a systematic review of current evidence. Eur Urol Open Sci. 2025;79:45\u201359.","journal-title":"Eur Urol Open Sci"},{"issue":"4","key":"2166_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/jpm14040392","volume":"14","author":"B Barone","year":"2024","unstructured":"Barone B, Napolitano L, Reccia P, Calace FP, De Luca L, Olivetta M, et al. Advances in urinary diversion: from cutaneous ureterostomy to orthotopic neobladder reconstruction\u2014a comprehensive review. J Pers Med. 2024;14(4):392.","journal-title":"J Pers Med"},{"key":"2166_CR18","doi-asserted-by":"publisher","first-page":"102090","DOI":"10.1016\/j.suronc.2024.102090","volume":"55","author":"BF Mirto","year":"2024","unstructured":"Mirto BF, Barone B, Balsamo R, Abate M, Caputo VF, Sciarra A, et al. Early and late post-procedural complications in different orthotopic neobladder surgical approaches: a systematic review. Surg Oncol. 2024;55:102090.","journal-title":"Surg Oncol"},{"issue":"3","key":"2166_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","volume":"78","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen NJ, Omer A, Harriss E, Davies L, Kasivisvanathan V, Punwani S, et al. Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the Prostate Imaging Reporting and Data System era: a systematic review and meta-analysis. Eur Urol. 2020;78(3):402\u201314.","journal-title":"Eur Urol"},{"issue":"2","key":"2166_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/bju.16662","volume":"136","author":"R Ben-David","year":"2025","unstructured":"Ben-David R, Pellegrino F, Mehrazin R, Thomas J, Geduldig J, Lidagoster S, et al. Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy. BJU Int. 2025;136(2):321\u20138.","journal-title":"BJU Int"},{"issue":"10","key":"2166_CR21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1089\/end.2020.0112","volume":"34","author":"A Arora","year":"2020","unstructured":"Arora A, Pugliesi F, Zugail AS, Moschini M, Pazeto C, Macek P, et al. Comparing perioperative complications between laparoscopic and robotic radical cystectomy for bladder cancer. J Endourol. 2020;34(10):1033\u201340.","journal-title":"J Endourol"},{"key":"2166_CR22","doi-asserted-by":"publisher","unstructured":"Vulsteke C, Adra N, Danchaivijitr P, Sabadash M, Rodriguez-Vida A, Zhang Z, Atduev V, G\u00f6ger YE, Rausch S, Kang SH, Loriot Y, Bedke J, Galsky MD, O\u2019Donnell PH, von Amsberg G, Alimohamed N, Sulimka G, Gupta S, Paramonov V, Nakane K, KEYNOTE-905\/EV-303 Investigators. \u2026 (2026). Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. The New England journal of medicine, 10.1056\/NEJMoa2511674. Advance online publication. https:\/\/doi.org\/10.1056\/NEJMoa2511674.","DOI":"10.1056\/NEJMoa2511674"},{"key":"2166_CR23","doi-asserted-by":"publisher","unstructured":"Suartz CV, de Lima RD, de Almeida LS, Liebl B, Lopes RI, Branquinho Reis GB, Henry Sant'Anna PV, Faris de Campos VD, Mota JM, Lima Aguiar Mel\u00e3o BV, Nahas WC, Shahrour W, Shabana W, Ribeiro-Filho LA, Toren P, Fradet V. Neoadjuvant immunotherapy in bladder cancer: ushering in a new era of treatment-a systematic review of current evidence. Eur Urol Open Sci. 2025 Aug 6;79:45\u201359. PMID: 40822997; PMCID: PMC12351343. https:\/\/doi.org\/10.1016\/j.euros.2025.07.010.","DOI":"10.1016\/j.euros.2025.07.010"},{"key":"2166_CR24","doi-asserted-by":"publisher","unstructured":"Suartz CV, Martinez LM, Cordeiro MD, Botelho LAA, Gallutti FP, Mota JM, Leite KRM, Toren P, Nahas WC, Ribeiro-Filho LA. Honing the hunt: a comprehensive review of cell-free tumor DNA to predict neoadjuvant therapy efficacy in bladder cancer. Clin Genitourin Cancer. 2024;22(3):102087. Epub 2024 Apr 6. PMID: 38688207. https:\/\/doi.org\/10.1016\/j.clgc.2024.102087.","DOI":"10.1016\/j.clgc.2024.102087"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02166-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:03:06Z","timestamp":1786014186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02166-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2166"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02166-6","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Institutional Research Ethics Committee under approval number CCEP: 5063\/24. Due to the retrospective nature of the study and the use of anonymized data obtained from medical records, the requirement for informed consent was waived. All procedures were conducted in accordance with the ethical standards of the institutional committee and with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"189"}}